Karin Dahlman-Wright Selected Research

Estrogen Receptor beta

1/2014	Estrogen receptor beta in breast cancer.
6/2010	Genome-wide mapping of estrogen receptor-beta-binding regions reveals extensive cross-talk with transcription factor activator protein-1.
10/2009	Microarray analysis of altered gene expression in ERbeta-overexpressing HEK293 cells.
9/2009	Effects of two common polymorphisms in the 3' untranslated regions of estrogen receptor beta on mRNA stability and translatability.
2/2008	Estrogen receptor beta: an overview and update.
4/2007	Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.
3/2006	Estrogen receptor beta polymorphism is associated with prostate cancer risk.
3/2006	Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production.
12/2005	Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production.
12/2004	Difference in skeletal muscle function in males vs. females: role of estrogen receptor-beta.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karin Dahlman-Wright Research Topics

Disease

17	Breast Neoplasms (Breast Cancer) 10/2019 - 06/2003
8	Insulin Resistance 01/2018 - 03/2006
8	Neoplasms (Cancer) 03/2016 - 04/2007
8	Obesity 01/2016 - 12/2006
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2012 - 01/2003
5	Inflammation (Inflammations) 01/2018 - 08/2012
5	Type 2 Diabetes Mellitus (MODY) 01/2017 - 11/2008
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 12/2010
4	Triple Negative Breast Neoplasms 09/2017 - 04/2015
3	Weight Loss (Weight Reduction) 01/2017 - 03/2008
3	Metabolic Diseases (Metabolic Disease) 01/2017 - 12/2010
2	Neoplasm Metastasis (Metastasis) 10/2016 - 03/2016
2	Carcinogenesis 09/2013 - 10/2003
2	Body Weight (Weight, Body) 01/2013 - 10/2008
2	Prostatic Neoplasms (Prostate Cancer) 07/2011 - 03/2006
2	Fatigue 06/2009 - 12/2004
1	Hypoxia (Hypoxemia) 09/2017
1	Hypertrophy 06/2014
1	Keratosis 01/2014
1	Carcinoma (Carcinomatosis) 09/2013
1	Communicable Diseases (Infectious Diseases) 04/2012
1	Infections 04/2012
1	Hypertension (High Blood Pressure) 01/2012
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2011
1	Dementia (Dementias) 01/2011
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2011
1	Alzheimer Disease (Alzheimer's Disease) 01/2011
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2010
1	Disease Susceptibility (Diathesis) 09/2009
1	Glucose Intolerance 11/2008
1	Animal Disease Models 02/2008
1	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 02/2007

Drug/Important Bio-Agent (IBA)

19	Estrogens (Estrogen)FDA Link 01/2019 - 01/2003
13	Estrogen ReceptorsIBA 10/2019 - 03/2006
12	Estrogen Receptor betaIBA 01/2014 - 06/2003
9	Estrogen Receptor alphaIBA 01/2019 - 04/2007
9	Messenger RNA (mRNA)IBA 03/2016 - 10/2003
8	Glucose (Dextrose)FDA LinkGeneric 01/2013 - 03/2006
6	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2018 - 06/2010
6	Proteins (Proteins, Gene)FDA Link 09/2017 - 04/2007
4	Tamoxifen FDA LinkGeneric 01/2018 - 12/2015
4	Hormones (Hormone)IBA 01/2016 - 04/2007
4	Protein Isoforms (Isoforms)IBA 04/2015 - 10/2003
4	Biomarkers (Surrogate Marker)IBA 09/2013 - 12/2005
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 06/2005
3	LigandsIBA 01/2018 - 02/2008
3	ChromatinIBA 04/2015 - 06/2010
3	Transcription Factors (Transcription Factor)IBA 06/2014 - 09/2012
3	Insulin (Novolin)FDA Link 01/2013 - 03/2006
3	Pharmaceutical PreparationsIBA 07/2011 - 01/2007
3	Liver X ReceptorsIBA 12/2010 - 12/2006
2	Choline (Choline Chloride)IBA 10/2019 - 10/2016
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2017 - 06/2006
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2017 - 01/2016
2	CytokinesIBA 03/2016 - 01/2016
2	Estradiol (Delestrogen)FDA LinkGeneric 01/2016 - 06/2006
2	EnzymesIBA 01/2016 - 12/2002
2	CholesterolIBA 12/2010 - 01/2007
2	Triglycerides (Triacylglycerol)IBA 06/2006 - 03/2006
2	IsoflavonesIBA 03/2006 - 12/2005
1	CC ChemokinesIBA 01/2018
1	ChemokinesIBA 01/2018
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 09/2017
1	HLA-DQA1 antigen (HLA DQA1)IBA 01/2016
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2016
1	Docosahexaenoic AcidsIBA 01/2016
1	LeptinIBA 01/2016
1	Insulin ReceptorIBA 01/2016
1	HLA-DQB1 antigen (HLA DQB1)IBA 01/2016
1	1- (2- (1- (2- aminopyrimidin- 4- yl)- 2- ((2- methoxyethyl)amino)- 1H- 1,3- benzodiazol- 6- yl)ethynyl)cyclohexan- 1- olIBA 12/2015
1	p21-Activated KinasesIBA 12/2015
1	Histone Deacetylase InhibitorsIBA 10/2015
1	(+)-JQ1 compoundIBA 10/2015
1	AntibodiesIBA 01/2014
1	Keratins (Keratin)IBA 01/2014
1	Phenobarbital (Luminal)FDA Link 09/2013
1	Progesterone Receptors (Progesterone Receptor)IBA 09/2013
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 09/2012
1	MicroRNAs (MicroRNA)IBA 08/2012
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 08/2012
1	HDL LipoproteinsIBA 01/2012
1	C-PeptideIBA 10/2011
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 06/2011
1	P-2 (P 2)IBA 06/2011
1	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 06/2011
1	Small Interfering RNA (siRNA)IBA 06/2010
1	Cyclin B1IBA 02/2010
1	Protein Kinases (Protein Kinase)IBA 02/2010
1	3' Untranslated Regions (3' UTR)IBA 09/2009
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2007
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 06/2006
1	Biological ProductsIBA 03/2006
1	oxidized low density lipoproteinIBA 03/2006
1	LDL CholesterolIBA 03/2006
1	HDL CholesterolIBA 03/2006

Therapy/Procedure

2	Therapeutics 11/2016 - 01/2016
1	Glycemic Control 01/2017
1	Estrogen Replacement Therapy 01/2017
1	Drug Therapy (Chemotherapy) 01/2016
1	Bariatric Surgery 01/2016